Healthcare -
Biotechnology - NASDAQ - US
$ 2.02
3.06 %
$ 62.7 M
Market Cap
-1.03
P/E
Price Target
Average
568.32%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
10.23%
Net Income
Estimate
22.97%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Immuneering Corporation
Wall Street analysts predict an average 1-year price target for IMRX of $13.5 , with forecasts ranging from
a
low of
$3 to a high of $41 .
IMRX Lowest Price Target
Wall Street Target
3 USD
48.51%
IMRX Average Price Target
Wall Street Target
13.5 USD
568.32%
IMRX Highest Price Target
Wall Street Target
41 USD
1929.70%
REVENUE FORECAST
Revenue Forecast Chart IMRX
EBIT FORECAST
EBIT Forecast Chart IMRX
NET INCOME FORECAST
Net Income Chart IMRX